Shared on 24 Oct 25
Fair value Decreased 2.89%Analysts have lowered their price target for Align Technology by approximately $5 to $175. They cite slightly softer revenue growth projections, modestly reduced profit margin expectations, and increased uncertainty around guidance for the upcoming quarters.
Shared on 10 Oct 25
Fair value Decreased 3.26%Emerging Markets And Digital Workflow Will Fuel Future Success
Analysts have modestly lowered their price target for Align Technology, trimming it by approximately $6 to $180. Updated industry surveys and company results reflect both ongoing optimism and continued challenges in the dental market.
Shared on 04 Aug 25
Fair value Decreased 20%Emerging Markets And Digital Workflow Will Fuel Future Success
The significant reduction in Align Technology’s analyst price target reflects lowered revenue growth expectations and a material contraction in its future P/E multiple, resulting in a revised fair value of $186.36. What's in the News Align provided Q3 2025 revenue guidance of $965–$985 million, down sequentially; full-year 2025 revenue is expected to be flat to slightly up, with low-single digit clear aligner volume growth.
Shared on 07 May 25
Fair value Increased 4.88%Invisalign And iTero Lumina Will Expand Global Reach
Shared on 30 Apr 25
Fair value Decreased 4.74%Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Fair value Decreased 0.42%Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 16 Apr 25
Fair value Decreased 5.46%Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 1.07%Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 1.19%Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 0.92%Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Increased 7.69%Invisalign And iTero Lumina Will Expand Global Reach
AnalystConsensusTarget has decreased revenue growth from 7.5% to 5.3%.